Cadrenal Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Cadrenal Therapeutics, Inc. (CVKD) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $299.10 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-03-31
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $299.10K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $299.10K.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $190.83K.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $885.44K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2025-12-31 | $299.10K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $299.10K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $190.83K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $885.44K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $420.72K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $327.00K 10-Q · filed 2024-11-07 | |
| 2023-12-31 | $105.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $42.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $997.50K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $808.50K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $105.00K 10-K · filed 2024-03-11 | $4.58M 10-K · filed 2023-03-30 |
| 2022-12-30 | $4.58M 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |